特變電工(600089.SH):子公司擬出資7.70億元參設雙碳綠能基金
格隆匯2月18日丨特變電工(600089.SH)公佈,公司全資子公司科技投資公司與南網建鑫基金管理有限公司(簡稱南網建鑫基金管理公司)、南方電網資本控股有限公司(簡稱南網資本)成立網雙碳綠能(廣州)私募股權投資基金合夥企業(有限合夥)(簡稱雙碳綠能基金,最終名稱以工商核准登記為準),通過雙碳綠能基金投資綠色清潔能源項目。
雙碳綠能基金註冊資本11億元,公司全資子公司特變電工科技投資有限公司(簡稱科技投資公司)認繳出資7.70億元,佔比70%。科技投資公司是有限合夥人,對合夥企業的債務承擔有限責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.